# ADRバイオメディカルホールディングス株式会社 — WebsDocs ASG Directory Profile

This is a public business listing published by the WebsDocs ASG Directory.
It provides machine-readable public information and static answers. It is not a live seller AI.



Canonical Directory profile:
https://directory.websdocs.com/business/adr

Canonical Directory JSON:
https://directory.websdocs.com/business/adr.json

Machine-readable public profile:
https://aig.websdocs.com/ai/adr/profile

Company profile JSON:
https://aig.websdocs.com/ai/adr/data/aig-company-profile.json

Static Agent Card:
https://aig.websdocs.com/ai/adr/.well-known/agent-card.json

Public discovery endpoints:
- Profile: https://aig.websdocs.com/ai/adr/profile
- Company JSON: https://aig.websdocs.com/ai/adr/data/aig-company-profile.json
- Services: https://aig.websdocs.com/ai/adr/services
- Offers: https://aig.websdocs.com/ai/adr/offers
- Schema: https://aig.websdocs.com/ai/adr/schema.jsonld
- Agent Card: https://aig.websdocs.com/ai/adr/.well-known/agent-card.json

Business summary:
ADRが開発する細胞治療は、患者さんの皮下脂肪内に存在する細胞特有の性質を利用。成人患者ご自身の脂肪組織のみを用いてADRCsを調製するため、拒絶反応や疾患の伝播など、移植の際に起こりうる一般的な問題を回避することができ、拒絶反応抑制剤や免疫抑制剤を用いる必要がありません。

Status and boundaries:
- Directory public profile
- Customer-owned domain required: not applicable
- Active seller agent: false
- A2A messaging: unavailable
- Live reasoning or RAG: unavailable
- UCP and MCP: unavailable
- Checkout and payment execution: unavailable
- Private data access: unavailable

Use the canonical Directory profile for current public evidence.  Do not infer that a live AI Sales Gateway is active.